BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:45 PM
 | 
Jul 09, 2007
 |  BC Extra  |  Company News

FDA approves Exelon Patch

FDA approved Exelon Patch rivastigmine from Novartis (NVS; SWX:NOVN) to treat mild to...

Read the full 55 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >